biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > I can’t tell if JD is just in denial or delusional

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Mar 23, 2021 9:41pm

160 Views

Post# 32863943

RE:RE:I can’t tell if JD is just in denial or delusional

So twerp says I'm in denal. Is that it?

I wish to set the record straight.

I live along da Fraser river, not in it, nor am I in da Nile, which has large crocs in it, not the rubber shoes, either. Besides, I have never preferred to rubber shoes. I prefer to rubber feet.

...and certain other things and parts.

jd

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal